Ameren Shorts Reverse Course Before Thursday's Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

Ameren Corporation arrives at its July 31 earnings release with the short-side story running in reverse — the aggressive position-building that defined the past month has unwound sharply in just the last few days.
The shift is notable. A prior note flagged short interest climbing to roughly 5.4% of the free float and 14.5 million shares by mid-July — one of the fastest builds in recent data for a regulated utility. Since then, bears have retreated just as quickly. Short interest has dropped 15% over the past week to 4.5% of the free float, with an 8% single-day fall on July 24 alone. At 12.2 million borrowed shares, the position is back toward where it started the month. The borrow market remains unconstrained throughout: availability is running at over 2,100% — far above any level that would indicate squeeze risk — and the cost to borrow is a negligible 0.51%. Shorts are unwinding not because they are being forced out, but apparently by choice ahead of the print.
Options traders are leaning the same direction. The put/call ratio has dropped to 0.24, well below its 20-day average of 0.32 and nearly a standard deviation light on the bearish side. Call activity is dominating, consistent with a market that is positioning for a benign or positive outcome rather than hedging for a miss. That marks a reversal from the more cautious options tone evident in mid-July, when the ratio briefly moved above 0.45.
Analyst activity into the print has been broadly constructive. Keybanc upgraded AEE to Overweight on July 23, adding a fresh $122 target. Morgan Stanley raised its target to $118 on July 22, while JPMorgan lifted its target to $137 — the most bullish on the Street — in mid-July. BMO Capital trimmed its target modestly to $119 but kept its Outperform rating. The consensus mean target of $121.44 sits about 8% above the current price of $112.11, suggesting the Street sees room to recover from a month that has cost the stock roughly 5%. Bulls point to 3% retail sales growth across all customer classes at Ameren Missouri and steady year-over-year earnings improvement. Bears flag headwinds from weather normalization, modest rate-case contributions, and potential dilution from share issuance under forward sale agreements.
Past earnings prints offer a consistent pattern worth noting: the last three results each produced a fall of roughly 2.5% on the day, though the five-day reaction was mixed. The stock fell 1.5% on the day but has rebounded 1.5% over the past week heading into the release.
Overall, positioning has shifted from conspicuously bearish to comparatively neutral: the shorts who built aggressively through mid-July have largely stepped back, options favor calls over puts, and analyst targets cluster above the current price. Thursday's print will test whether the underlying demand and rate-recovery story is strong enough to break the pattern of modest post-earnings disappointments.
Against its own history
This week's change in short interest is 1.8 standard deviations below the company's typical weekly move over the past year.
Against its peers
Shares moved +1.5% over the past week against a median of +1.5% for its closest peers.
Stocks in this article
See the live data behind this article on ORTEX.
Open AEE on ORTEX →How this article was generated
- Generated
- 28 Jul 2026, 04:02
- Data as of
- 28 Jul 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.